Volasertib in paediatric patients with leukaemia or solid tumour.

• Research type

  Research Study

• Full title

  Open, non-controlled, dose escalating Phase I trial to evaluate the pharmacokinetics, pharmacodynamics, tolerability, and toxicity of volasertib in paediatric patients from 2 years to less than 18 years of age with acute leukaemia or advanced solid tumour, for whom no effective treatment is known.

• IRAS ID

  143401

• Contact name

  Andrew Pearson

• Contact email

  andrew.pearson@icr.ac.uk

• Sponsor organisation

  Boehringer Ingelheim

• Eudract number

  2013-001291-38

• ISRCTN Number

  N/A

• REC name

  London - South East Research Ethics Committee

• REC reference

  14/LO/0335

• Date of REC Opinion

  22 Apr 2014

• REC opinion

  Further Information Favourable Opinion